Virax Biolabs Introduces Monkeypox and Varicella-Zoster Viruses Real-Time PCR Detection Kit
Kits Available in July for Distribution London, United Kingdom, July 26, 2022 (GLOBE NEWSWIRE) —…
Month: July 2022
Paladin Phase 4 Study Confirms Safety of Durable ILUVIEN® Treatment and Reduces Burden of Care For DME Patients
Data from the recent 0.19 mg FAc implant Phase 4 observational real-world study were presented…
CinCor Pharma Announces Last Patient Randomized in Phase 2 HALO Trial and Initiation of Long-Term Extension Study for Baxdrostat, a Selective Aldosterone Synthase Inhibitor, in Uncontrolled Hypertension
Open Label Extension Study Will Evaluate Baxdrostat for Up to 52 Weeks Topline Data for…
PDS Biotechnology Announces Conference Call and Webcast for Second Quarter 2022 Financial Results
FLORHAM PARK, N.J., July 26, 2022 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a…
Spectral Medical’s Chief Medical Officer, Dr. John Kellum, to be the Featured Speaker in Webinar Hosted by Sepsis Alliance
TORONTO, July 26, 2022 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:…
FDA Accepts Biogen’s New Drug Application and Grants Priority Review of Tofersen for a Rare, Genetic Form of ALS
SOD1-ALS is a rare genetic form of ALS that affects approximately 330 people in the…
Inozyme Pharma Secures Flexible Debt Facility for up to $70 Million with K2 HealthVentures
BOSTON, July 26, 2022 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare…
Entera Bio Announces Formation of Clinical and Scientific Advisory Board and Poster Presentation at ASBMR 2022 Annual Meeting
JERUSALEM, July 26, 2022 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the…
BridgeBio Pharma Announces Positive Interim Results from a Phase 2 Trial of Infigratinib in Achondroplasia Demonstrating an Increase in Annualized Height Velocity of 1.52 cm/year in Children 5 Years of Age and Older, and Adds 5th Cohort to Trial
– At the highest dose level evaluated to date (Cohort 4, 0.128 mg/kg once daily),…
Rapid Therapeutic Science Laboratories File S1 and completes Mid-Year Strategy Review
DALLAS, July 26, 2022 (GLOBE NEWSWIRE) — Rapid Therapeutics Science Laboratories (OTC: RTSL) (“Rapid Therapeutic”…
Reneo Pharmaceuticals Reports Positive Results from REN001 Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Study and Provides Additional Development Updates
LC-FAOD program to move forward into the next stage of clinical development Enrollment of pivotal…
InflaRx Announces Plans to Apply for Emergency Use Authorization from the US FDA for Vilobelimab for Treatment of Critically Ill COVID-19 Patients
Completed encouraging Type B meeting with US FDA Application for EUA planned to be submitted…
OpGen Subsidiary Ares Genetics GmbH Enters into Collaboration Agreement with the Belgian National Reference Centre for Invasive S. pneumoniae at UZ Leuven
Collaborators aim to develop and evaluate computation tools, including predictive models for whole genome sequencing-based…
Diffusion Pharmaceuticals to Initiate Phase 2 Trial in Patients with Glioblastoma Multiforme Incorporating Innovative Imaging Methodology to Evaluate Tumor Oxygenation
Diffusion aligns with FDA on design of an open-label, dose-escalation, Phase 2 safety and efficacy…
Xbox is here – experience next-gen 5G gaming at Verizon
Get Xbox and hundreds of games at Verizon with no money down. All with Xbox…
Vedder Price selects OnePlace Marketing & Business Development to drive organic growth
Industry-leading software will modernize growth strategies, enhance client experience, and put firmwide information into lawyers’…
GoTo Receives TMC’s 2022 Unified Communications Product of the Year Award for UCaaS product, GoTo Connect
GoTo Connect was awarded for exceptional innovation following the company’s February rebrand and launch of…
The Summon Platform, Advanced New DAO Solution on Cardano Announces Community Utility Token Distribution
Distribution of SUMMON utility/governance tokens to debut mid-August, 2022; supporters can chip-in to help speed…
Definitive Healthcare launches Passport Express to provide ready-to-use healthcare commercial intelligence for biopharma
New product integrates comprehensive analytics built by Analytical Wizards with industry-leading data from Definitive Healthcare…
Tresata Launches Digital Business Platform to Tackle the $200 Billion Data Usability Opportunity
Built exclusively for data clouds, the Tresata Digital Business Platform (DBP) empowers businesses to liberate…